Adial Pharmaceuticals (NASDAQ: ADIL)

Adial pharmaceuticals (nasdaq: adil) email format

Verified email-pattern data for Adial Pharmaceuticals (Nasdaq: Adil) is currently limited. You can still use the company insights and contact sections below.
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company’s landmark ONWARD™ Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company’s proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.

Company Details

Employees
14
Founded
-
Address
4870 Sadler Rd,
Industry
Pharmaceutical Manufacturing
Website
https://www.adial.com/
Keywords
drug abuse, drug addiction, alcohol abuse, alcohol addiction.
HQ
Glen Allen, Virginia
Competitors
Entera Bio Ltd., Collegium Pharmaceutical, Inc., Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), Ribbon Bio, Charlottesville Angel Network, Cambrex, Aardvark Therapeutics, Adovate, Acumen Pharmaceuticals, Inc., Seaport Therapeutics.
Looking for a particular Adial Pharmaceuticals (NASDAQ: ADIL) employee's phone or email?

Adial Pharmaceuticals (Nasdaq: Adil) Questions

Explore related pages

Adial Pharmaceuticals (NASDAQ: ADIL) company profile Adial Pharmaceuticals (NASDAQ: ADIL) management contacts

Related company profiles:

Companies like Adial Pharmaceuticals (NASDAQ: ADIL)

Cambrex logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Cambrex

1.71K
Acumen Pharmaceuticals, Inc. logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Acumen Pharmaceutica...

68
Charlottesville Angel Network logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Charlottesville Ange...

18
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Arcutis Biotherapeut...

378
Entera Bio Ltd. logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Entera Bio Ltd.

20
Adovate logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Adovate

22
Aardvark Therapeutics logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Aardvark Therapeutics

30
Ribbon Bio logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Ribbon Bio

56
Seaport Therapeutics logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Seaport Therapeutics

55
Collegium Pharmaceutical, Inc. logo - Similar company to Adial Pharmaceuticals (NASDAQ: ADIL)

Collegium Pharmaceut...

413

Top Adial Pharmaceuticals (NASDAQ: ADIL) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant